Projekt

AMGEN202100057

Geplant · 2022 bis 2024

Art
Klinische Forschung
Reichweite
Multizentrisch, KSSG als teilnehmendes Zentrum
Bereiche
Status
Geplant
Start
2022
Ende
2024
Finanzierungsart
Industrie
Studiendesign
Multicenter, cross-sectional to summarize the Lp(a) distribution in subjects with history of MI and/or PCI. Subjects are eligible if their Lp(a) value is known to be >= 90mg/dl, or is unknown. In that case Lp(a) will be determined.
Projektpartner
Kardiologie und Endokrinologie, KSSG
Kurzbeschreibung/Zielsetzung

A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD).

The purpose of the study is to characterize the distribution of Lp(a) levels among subjects with ASCVD.